Roberto Colombo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Roberto Colombo has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Serretti
Department of Medicine and Surgery, Kore University of Enna, Enna, Italy
1 shared publication - Ashwin A. Patkar
Avance Psychiatry at Centers of Excellence, Raleigh, NC, USA
1 shared publication - Changsu Han
Department of Psychiatry, Korea University College of Medicine, Seoul, Korea
1 shared publication - Chi-Un Pae
Department of Psychiatry, College of Medicine, The Catholic University of Korea, Seoul, Korea
1 shared publication - Concetta Crisafulli
Department of Biomedical and Dental Sciences and Morpho-Functional Imaging—BIOMORF, University of Messina, 98125 Messina, Italy
1 shared publication - Enzo Emanuele
E Science, I-27038 Robbio, PV, Italy
1 shared publication
Latest Publications
- Open Access
- 31 May 2020
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 18 (2) , 231-240
ZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, Marco Di Nicola, Roberto Colombo, Luigi Janiri, Soo-Jung Lee, Tae-Youn Jun, Sheng-Min Wang, Prakash S. Masand, Ashwin A. Patkar, Changsu Han, Chi-Un Pae, Alessandro Serretti. Clin Psychopharmacol Neurosci 2020;18:231-40. https://doi.org/10.9758/cpn.2020.18.2.231
- 31 May 2020
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 18 (2) , 231-240
Open AccessZNF804A Gene Variants Have a Cross-diagnostic Influence on Psychosis and Treatment Improvement in Mood Disorders
Marco Calabrò, Laura Mandelli, Concetta Crisafulli, Marco Di Nicola, Roberto Colombo, Luigi Janiri, Soo-Jung Lee, Tae-Youn Jun, Sheng-Min Wang, Prakash S. Masand, Ashwin A. Patkar, Changsu Han, Chi-Un Pae, Alessandro Serretti. Clin Psychopharmacol Neurosci 2020;18:231-40. https://doi.org/10.9758/cpn.2020.18.2.231
- 1 January 2010
- Vol. 31 (1) , 117-21
Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.
Previous studies have suggested that the endogeneous psychotomimetic molecule bufotenine (N-N-dimethyl-5-idroxytryptamine) may play a role in the pathogenesis of severe mental disorders. The potential association of bufotenine with the clinical features of autism and schizophrenia is not entirely understood. In this study, we measured urinary levels of bufotenine in subjects with autistic spectrum disorder (ASD), schizophrenia and healthy comparison subjects free of psychiatric symptoms. We also sought to assess whether urine concentrations of this molecule may be associated with the clinical characteristics of psychiatric patients. Urine bufotenine levels were measured using a high-performance liquid chromatography-mass spectrometry (HPLC-MS) assay in young adults with severe ASD (n=15), patients with schizophrenia (n=15), and healthy control subjects (n=18). The Vineland Adaptive Behavior Scale was used to measure adaptive behaviors in ASD individuals. The Brief Psychiatric Rating Scale (BPRS) was used for patients with schizophrenia. Urine bufotenine levels were significantly higher in ASD subjects (3.30 +/- 0.49 microg/L, p<0.05) and patients with schizophrenia (4.39 +/- 0.43 microg/L, p<0.001) compared with controls (1.53 +/- 0.30 microg/L). Among patients with ASD, there was a significant positive correlation between urine bufotenine and hyperactivity scores on the Vineland Adaptive Behavior Scale (r=0.479, p<0.05). No other associations were detected. Our results indicate that elevated urine levels of the endogeneous psychotomimetic molecule bufotenine may play a role in ASD and schizophrenia, and can be correlated with hyperactivity scores in autism.
- 1 January 2010
- Vol. 31 (1) , 117-21
Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.
Previous studies have suggested that the endogeneous psychotomimetic molecule bufotenine (N-N-dimethyl-5-idroxytryptamine) may play a role in the pathogenesis of severe mental disorders. The potential association of bufotenine with the clinical features of autism and schizophrenia is not entirely understood. In this study, we measured urinary levels of bufotenine in subjects with autistic spectrum disorder (ASD), schizophrenia and healthy comparison subjects free of psychiatric symptoms. We also sought to assess whether urine concentrations of this molecule may be associated with the clinical characteristics of psychiatric patients. Urine bufotenine levels were measured using a high-performance liquid chromatography-mass spectrometry (HPLC-MS) assay in young adults with severe ASD (n=15), patients with schizophrenia (n=15), and healthy control subjects (n=18). The Vineland Adaptive Behavior Scale was used to measure adaptive behaviors in ASD individuals. The Brief Psychiatric Rating Scale (BPRS) was used for patients with schizophrenia. Urine bufotenine levels were significantly higher in ASD subjects (3.30 +/- 0.49 microg/L, p<0.05) and patients with schizophrenia (4.39 +/- 0.43 microg/L, p<0.001) compared with controls (1.53 +/- 0.30 microg/L). Among patients with ASD, there was a significant positive correlation between urine bufotenine and hyperactivity scores on the Vineland Adaptive Behavior Scale (r=0.479, p<0.05). No other associations were detected. Our results indicate that elevated urine levels of the endogeneous psychotomimetic molecule bufotenine may play a role in ASD and schizophrenia, and can be correlated with hyperactivity scores in autism.
- 9 June 2009
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 25 (3) , 368-370
From Apneic Spells to the Development of Hypertensive Hydrocephalus: A Case Report of Homocystinuria With Early Onset
Homocystinuria represents a group of hereditary metabolic disorders characterized by an accumulation of homocysteine in the serum and an increased excretion of homocysteine in the urine. The infantile form is severe: the main clinical findings are neurologic signs, associated with hematological signs and bone alterations. Immediate restoration of plasma amino acids is the primary goal and early diagnosis is crucial not to delay the onset of possible treatment. We report a case of homocystinuria with early onset: an initial symptomatology was undervalued by the pediatrician with a delay in diagnosis. Despite the therapy, the patient developed tetraventricular hydrocephalus requiring ventricular drainage. In conclusion, we want to remember the necessity to perform a complete metabolic workup in a patient with clinical manifestations suggestive for homocystinuria, and the importance of early recognition of the signs and symptoms of hypertensive hydrocephalus, a possible complication of this condition.
- 9 June 2009
- Published by SAGE Publications in Journal of Child Neurology
- Vol. 25 (3) , 368-370
From Apneic Spells to the Development of Hypertensive Hydrocephalus: A Case Report of Homocystinuria With Early Onset
Homocystinuria represents a group of hereditary metabolic disorders characterized by an accumulation of homocysteine in the serum and an increased excretion of homocysteine in the urine. The infantile form is severe: the main clinical findings are neurologic signs, associated with hematological signs and bone alterations. Immediate restoration of plasma amino acids is the primary goal and early diagnosis is crucial not to delay the onset of possible treatment. We report a case of homocystinuria with early onset: an initial symptomatology was undervalued by the pediatrician with a delay in diagnosis. Despite the therapy, the patient developed tetraventricular hydrocephalus requiring ventricular drainage. In conclusion, we want to remember the necessity to perform a complete metabolic workup in a patient with clinical manifestations suggestive for homocystinuria, and the importance of early recognition of the signs and symptoms of hypertensive hydrocephalus, a possible complication of this condition.